Prometheus Biosciences, Inc., a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of complementary diagnostic and precision therapeutics for the treatment and diagnosis of inflammatory bowel diseases (IBD). The company is headquartered in San Diego, California.